Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1089 - 1096 of 12065 results
EnforceMintz — Health Care Enforcement Trends & 2024 Outlook
February 12, 2024| Blog| Viewpoint
New Opportunities from DOE for Domestic Manufacturing of Advanced Batteries
February 12, 2024| News
Need Prior Art? Here’s How to Search the PTO Database of Patents Like a Patent Examiner
February 12, 2024| Blog| Viewpoint
Sports Gambling in the Workplace: A Safe Bet?
February 10, 2024| Blog| Viewpoint
EnforceMintz — DOJ’s Limited Use of NPAs and DPAs in Criminal Health Care Investigations
February 8, 2024| Blog| Viewpoint
EnforceMintz — Some of 2023’s Largest FCA Resolutions Involved Stark Law Allegations
February 8, 2024| Blog| Viewpoint
EnforceMintz — Practical Lessons Learned from FCA Litigation in 2023
February 8, 2024| Blog| Viewpoint
EnforceMintz — DOJ’s Efforts in 2023 to Incentivize Voluntary Self-Disclosure
February 8, 2024| Blog| Viewpoint
News & Press Releases
Mintz Advises PHLUR on Acquisition by TSG Consumer
July 29, 2025
Mintz advised PHLUR, a modern fragrance brand recognized for its emotion-led storytelling and accessible positioning, in its acquisition by TSG Consumer, a leading private equity firm specializing in consumer brands.
Mintz Attorneys Named to Los Angeles Business Journal’s 2025 “Leaders of Influence: Litigators & Trial Attorneys” List
July 28, 2025
Mintz Member Esteban Moralesand Special Counsel Nada Shamonki has been recognized by Los Angeles Business Journal in its 2025 “Leaders of Influence: Litigators & Trial Attorneys” list which recognizes lawyers who “go to the proverbial mat to fight for their clients,” according to the publication.
Is Biopharma M&A In a Holding Pattern or a ‘New Normal’
July 23, 2025
Life Sciences International Chair Cheryl Reicin recently joined the Scrip M&A Podcast to share insights on the evolving landscape of biopharmaceutical mergers and acquisitions. In the episode, Cheryl highlights an uptick in pre-M&A activity, as major pharmaceutical companies increasingly leverage license and option agreements to strengthen their pipelines and product portfolios while positioning themselves for potential future acquisitions.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|